Meeder Asset Management’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-152
Closed -$5K 2452
2022
Q2
$5K Buy
152
+129
+561% +$4.08K ﹤0.01% 1682
2022
Q1
$1K Hold
23
﹤0.01% 2280
2021
Q4
$1K Sell
23
-9
-28% -$222 ﹤0.01% 1070
2021
Q3
$1K Buy
32
+1
+3% +$25 ﹤0.01% 2416
2021
Q2
$1K Sell
31
-7,280
-100% -$198K ﹤0.01% 2438
2021
Q1
$187K Buy
7,311
+7,279
+22,747% +$187K 0.01% 745
2020
Q4
$1K Buy
32
+1
+3% +$20 ﹤0.01% 1789
2020
Q3
$1K Buy
31
+22
+244% +$416 ﹤0.01% 2091
2020
Q2
$0 Sell
9
-1,384
-99% -$31.7K ﹤0.01% 2627
2020
Q1
$33K Sell
1,393
-3,930
-74% -$114K ﹤0.01% 1060
2019
Q4
$175K Buy
5,323
+658
+14% +$21.1K 0.01% 636
2019
Q3
$150K Buy
4,665
+4,442
+1,992% +$129K 0.01% 688
2019
Q2
$6K Sell
223
-1,230
-85% -$31.3K ﹤0.01% 1635
2019
Q1
$38K Buy
+1,453
New +$43.4K ﹤0.01% 938
2018
Q2
Sell
-67
Closed -$2K 1722
2018
Q1
$2K Buy
+67
New +$2.12K ﹤0.01% 1418

Other funds holding NTUS

Meeder Asset Management's NTUS Position: Q3 2022 in Review

Meeder Asset Management sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 152 shares — an estimated $5K sold.

Meeder Asset Management first reported a position in NTUS in Q1 2018 and held it in 15 quarters. The position peaked at $187K in Q1 2021. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Meeder Asset Management reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Meeder Asset Management sold 152 Natus Medical Inc shares in Q3 2022, an estimated $5K.
  • Meeder Asset Management first reported a position in Natus Medical Inc in Q1 2018 and held it in 15 quarters.
  • Meeder Asset Management's Natus Medical Inc position peaked at $187K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Meeder Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.